Carrie J Finno Selected Research

Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile)

9/2021	Increased α-tocopherol metabolism in horses with equine neuroaxonal dystrophy.
9/2018	Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy.
1/2018	A Missense Mutation in the Vacuolar Protein Sorting 11 (VPS11) Gene Is Associated with Neuroaxonal Dystrophy in Rottweiler Dogs.
7/2017	Pigment retinopathy in warmblood horses with equine degenerative myeloencephalopathy and equine motor neuron disease.
12/2016	Transcriptome profiling of equine vitamin E deficient neuroaxonal dystrophy identifies upregulation of liver X receptor target genes.
9/2012	Electrophysiological studies in American Quarter horses with neuroaxonal dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carrie J Finno Research Topics

Disease

8	Muscular Diseases (Myopathy) 09/2022 - 10/2003
6	Rhabdomyolysis 09/2022 - 01/2004
6	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 09/2021 - 09/2012
3	Myofibrillar Myopathy 03/2022 - 12/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 12/2016
2	Muscular Atrophy (Muscle Atrophy) 09/2022 - 11/2019
2	Atrophy 12/2021 - 09/2018
2	Vitamin E Deficiency 05/2021 - 11/2019
2	Ataxia (Dyssynergia) 11/2019 - 07/2017
2	Neurologic Manifestations (Neurological Manifestations) 09/2012 - 09/2011
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2022
1	Spinal Cord Compression 03/2022
1	Chronic Pain 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Inflammation (Inflammations) 12/2021
1	Hemorrhage 01/2021
1	Hypoparathyroidism 01/2020
1	Myalgia 12/2018
1	Osteoporosis 01/2018
1	Silicosis 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Leukoencephalopathies 01/2018
1	Motor Neuron Disease (Primary Lateral Sclerosis) 07/2017
1	Ataxia with vitamin E deficiency 12/2016
1	Clinical Deterioration 07/2010
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 03/2009
1	Asthenia 03/2009
1	Hyperkalemic Periodic Paralysis 03/2009
1	Glycogen Storage Disease Type IV (Andersen's Disease) 03/2009
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2009
1	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 03/2009
1	Malignant Hyperthermia 03/2009

Drug/Important Bio-Agent (IBA)

5	Vitamin E FDA LinkGeneric 01/2022 - 09/2011
5	Tocopherols (Tocopherol)IBA 09/2021 - 12/2016
4	Myosin Heavy Chains (Myosin Heavy Chain)IBA 09/2022 - 03/2019
4	Polysaccharides (Glycans)IBA 03/2022 - 10/2003
4	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2016
3	NAD (NADH)IBA 01/2018 - 09/2012
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2019 - 12/2016
2	Creatine Kinase (Creatine Phosphokinase)IBA 09/2018 - 01/2004
1	ImmunosorbentsIBA 03/2022
1	EnzymesIBA 03/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	von Willebrand FactorIBA 01/2021
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 11/2019
1	alpha-Tocopherol FDA Link 11/2019
1	Adenosine Triphosphatases (ATPase)IBA 03/2019
1	sarcolipinIBA 03/2019
1	CalciumIBA 03/2019
1	Peptides (Polypeptides)IBA 03/2019
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 03/2019
1	Peroxiredoxin VIIBA 12/2018
1	Cysteine (L-Cysteine)FDA Link 12/2018
1	DesminIBA 12/2018
1	ProteomeIBA 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 09/2018
1	Biomarkers (Surrogate Marker)IBA 09/2018
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018
1	SoilIBA 01/2018
1	SilicatesIBA 01/2018
1	Myosins (Myosin)IBA 01/2018
1	Liver X ReceptorsIBA 12/2016
1	ponazurilIBA 07/2010
1	tremetoneIBA 10/2006
1	Dantrolene (Dantrium)FDA LinkGeneric 01/2004

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Oral Administration 01/2004